Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Videos

Benefits of Dual Treatment for MCL

constantine tamConstantine Tam, MD, director of Hematology, St Vincent Hospital, discusses the phase 3 SYMPATICO study that examined the use ibrutinib plus venetoclax for the treatment of mantle cell lymphoma. 

 

Advertisement

Advertisement

Advertisement